A Study of TQH2722 Injection to Evaluate the Safety, Tolerability, Pharmacokinetics, Efficacy and Immunogenicity in Healthy Adult Subjects

Conditions

• Atopic Dermatitis

Interventions

• DRUG: TQH2722 injection
• DRUG: Placebo to match TQH2722

Sponsor

Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.